专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20220185879A1 IL17A Antibodies and Antagonists for Veterinary Use 有权
公开(公告)号：US20220185879A1
公开(公告)日：2022-06-16
申请号：US17687083
申请日：2022-03-04
申请人： Kindred Biosciences, Inc.
发明人： Shyr Jiann Li , Lam Nguyen , Lan Yang , Hangjun Zhan
IPC分类号： C07K16/24 , A61K39/395 , C12N15/63
摘要： Provided are various embodiments relating to anti-IL17A antibodies and IL17Ra ECD polypeptides that bind to IL17A. In various embodiments, such anti-IL17A antibodies or IL17Ra ECD polypeptides can be used in methods to treat IL17-induced conditions in subjects, such as humans or companion animals, such as canines, felines, and equines. Also provided are various embodiments relating to IgG Fc variant polypeptides having one or more amino acid substitutions for reducing binding to C1q and/or CD16. In some embodiments, the IgG Fc variants and/or polypeptides comprising the IgG Fc variants (e.g., fusion polypeptides comprising the IgG Fc variants and the anti-IL17A antibodies and/or IL17Ra ECD polypeptides described herein) may have reduced complement-mediated immune responses and/or antibody-dependent cell-mediated cytotoxicity.

2. 发明授权

US10150810B2 Anti-IL31 antibodies for veterinary use 有权
公开(公告)号：US10150810B2
公开(公告)日：2018-12-11
申请号：US15844142
申请日：2017-12-15
申请人： Kindred Biosciences, Inc.
发明人： Shyr Jiann Li , Lam Nguyen , Hangjun Zhan
IPC分类号： A61K39/395 , C07K16/24
摘要： Provided are various embodiments relating to anti-IL31 antibodies binding to canine IL31. Such antibodies can be used in methods to treat IL31-induced conditions in companion animals, such as canines, felines, and equines.

3. 发明申请

US20180071256A1 COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF PYREXIA IN HORSES 审中-公开
公开(公告)号：US20180071256A1
公开(公告)日：2018-03-15
申请号：US15554568
申请日：2016-03-02
申请人： Kindred Biosciences, Inc.
发明人： Emily Sundman
IPC分类号： A61K31/4152 , A61K47/38 , A61K47/14 , A61K47/10
摘要： Methods for treating and preventing pyrexia and other diseases in equines such as horses involving administering an oral pharmaceutical formulation containing metamizole are disclosed.

4. 发明申请

US20200330436A1 Compositions and Methods for Treatment and Prevention of Pyrexia in Horses 审中-公开
公开(公告)号：US20200330436A1
公开(公告)日：2020-10-22
申请号：US16869018
申请日：2020-05-07
申请人： Kindred Biosciences, Inc.
发明人： Emily Sundman
IPC分类号： A61K31/4152 , A61K47/38 , A61K9/06 , A61K9/08 , A61K47/36 , A61K47/10 , A61K47/14
摘要： Methods for treating and preventing pyrexia and other diseases in equines such as horses involving administering an oral pharmaceutical formulation containing metamizole are disclosed.

5. 发明申请

US20180244767A1 ANTI-IL31 ANTIBODIES FOR VETERINARY USE 审中-公开
公开(公告)号：US20180244767A1
公开(公告)日：2018-08-30
申请号：US15844142
申请日：2017-12-15
申请人： Kindred Biosciences, Inc.
发明人： Shyr Jiann Li , Lam Nguyen , Hangjun Zhan
IPC分类号： C07K16/24
CPC分类号： C07K16/244 , A61K2039/552 , C07K2317/24 , C07K2317/33 , C07K2317/34 , C07K2317/52 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92
摘要： Provided are various embodiments relating to anti-IL31 antibodies binding to canine IL31. Such antibodies can be used in methods to treat IL31-induced conditions in companion animals, such as canines, felines, and equines.

6. 发明申请

US20140180709A1 METHODS FOR DRUG DELIVERY 审中-公开
标题翻译：药物递送方法
公开(公告)号：US20140180709A1
公开(公告)日：2014-06-26
申请号：US14135261
申请日：2013-12-19
申请人： Kindred Biosciences, Inc.
发明人： Richard Chin
IPC分类号： G06F19/00
CPC分类号： G06F19/3456
摘要： Methods for delivering a drug to an animal while preventing or reducing the risk of exposure of a human to the drug are provided in which the involved prescribers, pharmacies, veterinarians, and/or owners are registered in one or more computer databases. Embodiments are also provided in which registered owners or other registrants receive counseling information concerning the risks attendant to human exposure to the drug. Embodiments are also provided in which a global positioning system, mobile device, Internet, radio frequency identification chips, and/or other electronic devices and systems are utilized.
摘要翻译：提供了在一种或多种计算机数据库中注册所涉及的处方者，药房，兽医和/或所有者的情况下，向药物递送药物同时预防或降低人暴露于药物的风险的方法。还提供了实施方案，其中登记所有者或其他注册者接收关于人接触该药物的风险的咨询信息。还提供了使用全球定位系统，移动设备，因特网，射频识别芯片和/或其他电子设备和系统的实施例。

7. 发明申请

US20220169740A1 NGF Antagonists for Medical Use 有权
公开(公告)号：US20220169740A1
公开(公告)日：2022-06-02
申请号：US17439972
申请日：2020-03-20
申请人： Kindred Biosciences, Inc.
发明人： Hangjun Zhan , Lam Nguyen , Richard Chin , Fawn Qian , Shyr Jiann Li , Qingyi Chu
IPC分类号： C07K16/28 , C12N9/12
摘要： Provided are various embodiments relating to TrkA ECD polypeptides from companion animal species that bind to NGF. Such polypeptides can be used in methods to treat NGF-induced condition related to chronic pain and/or inflammatory pain in companion animals, such as canines, felines, and equines.

8. 发明授权

US11299540B2 IL17A antibodies and antagonists for veterinary use 有权
公开(公告)号：US11299540B2
公开(公告)日：2022-04-12
申请号：US16621012
申请日：2018-06-18
申请人： Kindred Biosciences, Inc.
发明人： Shyr Jiann Li , Lam Nguyen , Lan Yang , Hangjun Zhan
IPC分类号： C07K16/24 , A61K39/395 , C12N15/63 , C12N5/10 , C07K14/755 , A61K39/00
摘要： Provided are various embodiments relating to anti-IL17A antibodies and IL17Ra ECD polypeptides that bind to IL17A. In various embodiments, such anti-IL17A antibodies or IL17Ra ECD polypeptides can be used in methods to treat IL17-induced conditions in subjects, such as humans or companion animals, such as canines, felines, and equines. Also provided are various embodiments relating to IgG Fc variant polypeptides having one or more amino acid substitutions for reducing binding to C1q and/or CD16. In some embodiments, the IgG Fc variants and/or polypeptides comprising the IgG Fc variants (e.g., fusion polypeptides comprising the IgG Fc variants and the anti-IL17A antibodies and/or IL17Ra ECD polypeptides described herein) may have reduced complement-mediated immune responses and/or antibody-dependent cell-mediated cytotoxicity.

9. 发明申请

US20210388053A1 Fc Variants with Altered Binding to Neonatal Fc Receptor (FCRN) for Veterinary Use 有权
公开(公告)号：US20210388053A1
公开(公告)日：2021-12-16
申请号：US17284875
申请日：2019-10-18
申请人： Kindred Biosciences, Inc.
发明人： Hangjun Zhan , Lam Nguyen , Qingyi Chu , Richard Chin , Shyr Jiann Li
IPC分类号： C07K14/705
摘要： Provided are various embodiments relating to variant IgG Fc polypeptides with altered FcRn binding activity. Also provided are polypeptides and pharmaceutical compositions comprising the variant IgG Fc polypeptides described herein. Polypeptides comprising variant IgG Fc polypeptides of the present invention may have extended half-life in vivo. Such products may be used in methods to treat disease in companion animals, such as canines, felines, and equines.

10. 发明申请

US20210032305A1 Erythropoietin and Analogs for Veterinary Use 有权
公开(公告)号：US20210032305A1
公开(公告)日：2021-02-04
申请号：US16617380
申请日：2018-06-05
申请人： Kindred Biosciences, Inc.
发明人： Hangjun Zhan , Lam Nguyen , Yongzhong Li , Qingyi Chu , Estela Garcia-Murillo , Victoria Leitman , Stephen Sundlof , Richard Chin , Shyr Jiann Li
IPC分类号： C07K14/505 , A61K47/60 , A61K47/26
摘要： Provided are various embodiments relating to feline erythropoietin (EPO) polypeptide analogs with one or more additional glycosylation sites and methods of producing and using the same to treat anemia in companion animals. Also provided are various embodiments relating to EPO polypeptides having a mutation in the second binding site, polypeptides comprising an extracellular domain of EPO receptor, and methods of using the same for treating polycythemia in mammals.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式